Hochschulschrift
Characterization of heterogenous HCV-specific CD8⁺ T cells in chronic and DAA-cured HCV with a focus on a memory-like subset
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
II, 122 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Albert-Ludwigs-Universität Freiburg, Dissertation, 2023
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:44 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- Mai 2023
Other Objects (12)
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
Evaluation of HCV-related liver fibrosis post-successful DAA therapy
HCV
Treatment and re-treatment results of HCV patients in the DAA era
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
HCV resistance
Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia
No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients
HCV Seroreactivity and Detection of HCV RNA in Hepatitis Cases
Towards HCV extinction with modern HCV treatment? “Yes we can !”
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
Evaluation of HCV-related liver fibrosis post-successful DAA therapy
HCV
Treatment and re-treatment results of HCV patients in the DAA era
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
HCV resistance
Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia
No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients
HCV Seroreactivity and Detection of HCV RNA in Hepatitis Cases
Towards HCV extinction with modern HCV treatment? “Yes we can !”
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
Evaluation of HCV-related liver fibrosis post-successful DAA therapy
HCV
Treatment and re-treatment results of HCV patients in the DAA era
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
HCV resistance
Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia
No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients
HCV Seroreactivity and Detection of HCV RNA in Hepatitis Cases
Towards HCV extinction with modern HCV treatment? “Yes we can !”